Vaccination directed against the human endogenous retrovirus-K (HERV-K) gag protein slows HERV-K gag expressing cell growth in a murine model system

[11] Denner J(2011)Characterization of the human endogenous retrovirus K gag protein: identification of protease cleavage sites Retrovirology 8 21-4489

[12] Wang-Johanning F(2007)Reconstitution of an infectious human endogenous retrovirus PLoS Pathog 3 e10-120

[13] Liu J(1997)Poxviruses as expression vectors Curr Opin Biotechnol 8 573-933

[14] Rycaj K(2011)Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection J Virol 85 6977-2424

[15] Huang M(2012)HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates J Clin Invest 122 4473-694

[16] Tsai K(2008)The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer Curr Gene Ther 8 97-4588

[17] Rosen DG(2000)Biology of attenuated modified vaccinia virus ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the western reserve strain and advantages as a vaccine J Virol 74 923-296

[18] Chen DT(2012)HIV infection and HERV expression: a review Retrovirology 9 6-7805

[19] Lu DW(2007)T cell responses to human endogenous retroviruses in HIV-1 infection PLoS Pathog 3 e165-122

[20] Barnhart KF(2007)The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia Aids 21 2417-57

[11] Denner J(2011)Characterization of the human endogenous retrovirus K gag protein: identification of protease cleavage sites Retrovirology 8 21-4489

[12] Wang-Johanning F(2007)Reconstitution of an infectious human endogenous retrovirus PLoS Pathog 3 e10-120

[13] Liu J(1997)Poxviruses as expression vectors Curr Opin Biotechnol 8 573-933

[14] Rycaj K(2011)Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection J Virol 85 6977-2424

[15] Huang M(2012)HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates J Clin Invest 122 4473-694

[16] Tsai K(2008)The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer Curr Gene Ther 8 97-4588

[17] Rosen DG(2000)Biology of attenuated modified vaccinia virus ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the western reserve strain and advantages as a vaccine J Virol 74 923-296

[18] Chen DT(2012)HIV infection and HERV expression: a review Retrovirology 9 6-7805

[19] Lu DW(2007)T cell responses to human endogenous retroviruses in HIV-1 infection PLoS Pathog 3 e165-122

[20] Barnhart KF(2007)The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia Aids 21 2417-57